Log In
BCIQ
Print this Print this
 

BAY 1002670

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionOral progesterone receptor modulator
Molecular Target Progesterone receptor (PGR)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationUterine fibroids
Indication DetailsTreat symptomatic uterine fibroids
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today